Classifies xylazine as a Schedule III controlled dangerous substance, except when used in veterinary medicine.
This bill amends the New Jersey Controlled Dangerous Substances Act to classify xylazine as a Schedule III controlled dangerous substance, except when it is used in the course of veterinary medicine. Xylazine, known as "tranq" or "zombie drug," is an animal sedative that has been found in illegal street drugs, particularly opioids, enhancing their effects. The bill aims to protect citizens by regulating xylazine, which does not respond to opioid antidotes and can cause severe health issues.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.